Numeric
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-tables-e1-e4-2022-update_0.xlsx
January 01, 2022 - 13 mg/day Placebo NR NA NA NA NA 16 Short Industry Low
19808912 Selvarajah, 2010 RCT No Europe NPP Diabetic … Corresponding placebo NR NA NA NA NA 4 Short Industry Moderate
22921260 Toth, 2012 RCT No Canada NPP Diabetic … NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR NA
Selvarajah, 2010 None High NPP Diabetic … NA NA NA NA NR NR NA NA NR NR NR NR NR NR Fibromyalgia Impact Questionnaire
Toth, 2012 None Low NPP Diabetic … NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR
Toth, 2012 None Low NPP Diabetic
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F1-4.xlsx
January 01, 2022 - 13 mg/day Placebo NR NA NA NA NA 16 Short Industry Low
19808912 Selvarajah, 2010 RCT No Europe NPP Diabetic … Corresponding placebo NR NA NA NA NA 4 Short Industry Moderate
22921260 Toth, 2012 RCT No Canada NPP Diabetic … NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR NA
Selvarajah, 2010 None High NPP Diabetic … NA NA NA NA NR NR NA NA NR NR NR NR NR NR Fibromyalgia Impact Questionnaire
Toth, 2012 None Low NPP Diabetic … NR NR NR NR NR NA NA NA NA NA NA NA NA NA NA NR NR NA NA NR NR NR NR NR NR
Toth, 2012 None Low NPP Diabetic
effectivehealthcare.ahrq.gov/products/diabetes-behavior-programs/clinician-2016
effectivehealthcare.ahrq.gov/products/diabetes-behavior-programs/clinician
effectivehealthcare.ahrq.gov/products/treatment-outcomes-diabetes/rapid-research
effectivehealthcare.ahrq.gov/products/diabetes-behavior-programs/espanol
effectivehealthcare.ahrq.gov/products/diabetes-behavior-programs/espanol-2017
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1306.pdf
July 01, 2013 - could present an opportunity to simplify treatment for the large
proportion of patients who are both diabetic … randomized controlled trial, SCALE™ (Satiety and Clinical Adiposity-Liraglutide Evidence in Non-
diabetic … and Diabetic people).49 The trial includes more than 5,000 patients who are either
overweight (BMIs
effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1406.pdf
June 01, 2014 - phentermine-
topiramate and could present an opportunity to simplify treatment for patients who are both diabetic … randomized controlled trial, SCALE™ (Satiety and Clinical Adiposity-Liraglutide Evidence in Non-
diabetic … and Diabetic people).56 The trial includes more than 5,000 patients who are either
overweight (BMIs
effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-drugs-utilization_research.pdf
January 25, 2011 - Utilization of antihypertensive drug classes among
Medicare beneficiaries with hypertension, 2007 to 2009
Cardiovascular Issues Data Points #8
Between 2007 and 2009,
87 to 88 percent of Medicare
beneficiaries with hypertension
used at least one prescription
for an antihypertensive drug.
Beneficiaries with hyp…
effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-nutrition-grand-rounds.pptx
September 08, 2025 - AHRQ Slide Template-Widescreen
AHRQ Evidence-based Practice Center Program
Grand Rounds Series
Topic: Nutrition
Welcome and thank you for joining!
September 8, 2025
Moderators
2
Elizabeth Cope, Ph.D., M.P.H.
Chief Programs and Science Officer – AcademyHealth
Lucy Savitz, Ph.D., M.B.A.
Professor – University…
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-pci-bypass_executive.pdf
October 01, 2007 - Layout 1
Background
Atherosclerosis develops in a patchy,
discontinuous fashion within coronary
arteries. Therefore, it is possible to treat
the discrete areas of obstruction that most
impede coronary blood flow to the
myocardium. The mechanical approaches
to coronary revascularization fall broadly
into two categor…
effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research-2007.pdf
January 01, 2007 - Survey of Medicare Part D Plans’ Medication Therapy Management Programs
Effective Health Care
Research Reports
Number 1
Survey of Medicare Part D Plans’
Medication Therapy Management Programs
Daniel R. Touchette, Pharm.D., M.A.
Anne L. Burns, R.Ph.
Marcie A. Bough, Pharm.D.
Juan C. Blackburn, M.D., M.B.…
effectivehealthcare.ahrq.gov/sites/default/files/pdf/patient-centered-medical-home_research-protocol.pdf
February 23, 2012 - Intermediate patient outcomes (e.g., change in HbA1c for diabetic patients).
b. … Intermediate patient outcomes (e.g., change in HbA1c for diabetic
patients).
ii.
effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-adults_research-protocol.pdf
December 01, 2010 - Major: mortality, cerebrovascular disease-related events, development of
diabetes mellitus, diabetic … Major: mortality, cerebrovascular disease-
related events, development of diabetes
mellitus, diabetic … adverse events: mortality, cerebrovascular disease-related events,
development of diabetes mellitus, diabetic
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-254-rural-telehealth-executive-summary.pdf
December 01, 2022 - Executive Summary_Comparative Effectiveness Review No. 254: Improving Rural Health Through Telehealth-Guided Provider-to-Provider Communication
Comparative Effectiveness Review
Number 254
Improving Rural Health Through
Telehealth-Guided Provider-to-Provider
Communication
Executive Summary
Main Points
• Use …
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - placebo-controlled, parallel assignment
efficacy study of nabilone as adjuvant in the
treatment of diabetic … placebo-controlled, parallel assignment
efficacy study of nabilone as adjuvant in the
treatment of diabetic … 0/32 (0%)
WAE: 2/34 (5.88%) vs.
0/32 (0%)
NR
Selvarajah, 2010
High
RCT
Neuropathic pain-
diabetic … (0%) vs. 0/18
(0%)
WAE: 1/20 (5%) vs. 1/20
(5%)
NR
Toth, 2012
Low
RCT
Neuropathic pain-
diabetic … Efficacy of Inhaled Cannabis on Painful
Diabetic Neuropathy.
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - placebo-controlled, parallel assignment
efficacy study of nabilone as adjuvant in the
treatment of diabetic … placebo-controlled, parallel assignment
efficacy study of nabilone as adjuvant in the
treatment of diabetic … 0/32 (0%)
WAE: 2/34 (5.88%) vs.
0/32 (0%)
NR
Selvarajah, 2010
High
RCT
Neuropathic pain-
diabetic … (0%) vs. 0/18
(0%)
WAE: 1/20 (5%) vs. 1/20
(5%)
NR
Toth, 2012
Low
RCT
Neuropathic pain-
diabetic … Efficacy of inhaled cannabis on painful
diabetic neuropathy.